Dr Reddy’s Laboratories to launch pain relief spray in India
Dr Reddy's Laboratories is reported to have introduced a pain relief spray under 'Nise D Spray' in the Indian market. This initiative can be viewed as a part of its efforts to increase its presence across the Indian over-the-counter (OTC) market.
With the entry in this new healthcare product vertical, Dr Reddy’s Laborataries is targeting to grab a share of the massive pain relief products in India, estimated to be around Rs 1700 crore.
To be made available in a pocket pack size priced at Rs 99, the spray will also come in an additional home pack for Rs 130, as confirmed the by the company in a press statement. Nise D spray offers quick and targeted pain killing, the company said.
Dr Reddy's EVP and Head Branded Markets (India & Emerging countries) MV Ramana said: "Nise D Spray marks our entry into the new segment and further boosts our OTC portfolio."
Dr Reddy's said that as per A C Nielsen Retail Measurement Study MAT August 2015, the market for pain relief products in India is approximately Rs 1,700 crore.
With the entry in this new healthcare product vertical, Dr Reddy’s Laborataries is targeting to grab a share of the massive pain relief products in India, estimated to be around Rs 1700 crore.
To be made available in a pocket pack size priced at Rs 99, the spray will also come in an additional home pack for Rs 130, as confirmed the by the company in a press statement. Nise D spray offers quick and targeted pain killing, the company said.
Dr Reddy's EVP and Head Branded Markets (India & Emerging countries) MV Ramana said: "Nise D Spray marks our entry into the new segment and further boosts our OTC portfolio."
Dr Reddy's said that as per A C Nielsen Retail Measurement Study MAT August 2015, the market for pain relief products in India is approximately Rs 1,700 crore.
Next Story
